Jim Wassil insider trades: Vaxcyte (PCVX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jim reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | PCVX | ↓ Sell | 2,250 | $60.90 | $137K | Direct | Nov 4, 2026 (2d) |
| Oct 5, 2026 | PCVX | ↓ Sell | 18,000 | $86.74 | $1.6M | Direct | Oct 7, 2026 (2d) |
| Oct 1, 2026 | PCVX | ↓ Sell | 2,250 | $56.67 | $128K | Direct | Oct 2, 2026 (1d) |
| Sep 1, 2026 | PCVX | ↓ Sell | 3,477 | $61.07 | $212K | Direct | Sep 2, 2026 (1d) |
| Aug 3, 2026 | PCVX | ↓ Sell | 2,250 | $53.86 | $121K | Direct | Aug 5, 2026 (2d) |
| Jul 1, 2026 | PCVX | ↓ Sell | 2,250 | $56.33 | $127K | Direct | Jul 6, 2026 (5d) |
| Jun 1, 2026 | PCVX | ↓ Sell | 2,250 | $49.52 | $111K | Direct | Jun 3, 2026 (2d) |
| Apr 1, 2026 | PCVX | ↓ Sell | 2,250 | $58.43 | $131K | Direct | Apr 3, 2026 (2d) |
| Mar 10, 2026 | PCVX | ↓ Sell | 7,395 | $58.88 | $435K | Direct | Mar 11, 2026 (1d) |
| Mar 3, 2025 | PCVX | ↓ Sell | 8,000 | $73.27 | $586K | Direct | Mar 3, 2025 (0d) |
| Feb 3, 2025 | PCVX | ↓ Sell | 8,000 | $86.22 | $690K | Direct | Feb 4, 2025 (1d) |
| Jan 2, 2025 | PCVX | ↓ Sell | 8,000 | $83.66 | $669K | Direct | Jan 3, 2025 (1d) |
| Dec 2, 2024 | PCVX | ↓ Sell | 8,000 | $92.49 | $740K | Direct | Dec 3, 2024 (1d) |
| Nov 1, 2024 | PCVX | ↓ Sell | 8,000 | $106.80 | $854K | Direct | Nov 4, 2024 (3d) |
| Oct 1, 2024 | PCVX | ↓ Sell | 8,000 | $114.24 | $914K | Direct | Oct 3, 2024 (2d) |
| Sep 16, 2024 | PCVX | ↓ Sell | 10,000 | $115.96 | $1.2M | Direct | Sep 18, 2024 (2d) |
| Sep 3, 2024 | PCVX | ↓ Sell | 10,000 | $111.93 | $1.1M | Direct | Sep 5, 2024 (2d) |
| Aug 1, 2024 | PCVX | ↓ Sell | 3,000 | $78.84 | $237K | Direct | Aug 5, 2024 (4d) |
| Jul 1, 2024 | PCVX | ↓ Sell | 3,000 | $76.34 | $229K | Direct | Jul 2, 2024 (1d) |
| Jun 3, 2024 | PCVX | ↓ Sell | 3,000 | $71.99 | $216K | Direct | Jun 5, 2024 (2d) |
| May 1, 2024 | PCVX | ↓ Sell | 3,000 | $61.65 | $185K | Direct | May 3, 2024 (2d) |
| Apr 1, 2024 | PCVX | ↓ Sell | 3,000 | $66.69 | $200K | Direct | Apr 3, 2024 (2d) |
| Mar 1, 2024 | PCVX | ↓ Sell | 3,000 | $73.71 | $221K | Direct | Mar 4, 2024 (3d) |
| Feb 1, 2024 | PCVX | ↓ Sell | 3,000 | $73.88 | $222K | Direct | Feb 5, 2024 (4d) |
| Jan 2, 2024 | PCVX | ↓ Sell | 3,000 | $63.91 | $192K | Direct | Jan 4, 2024 (2d) |
| Dec 1, 2023 | PCVX | ↓ Sell | 3,000 | $52.14 | $156K | Direct | Dec 5, 2023 (4d) |
| Nov 1, 2023 | PCVX | ↓ Sell | 3,000 | $47.26 | $142K | Direct | Nov 3, 2023 (2d) |
| Oct 2, 2023 | PCVX | ↓ Sell | 3,000 | $50.43 | $151K | Direct | Oct 4, 2023 (2d) |
| Sep 1, 2023 | PCVX | ↓ Sell | 3,000 | $52.82 | $158K | Direct | Sep 6, 2023 (5d) |
| Oct 17, 2022 | PCVX | ↓ Sell | 2,800 | $25.72 | $72K | Direct | Oct 19, 2022 (2d) |
| Sep 19, 2022 | PCVX | ↓ Sell | 2,800 | $26.11 | $73K | Direct | Sep 21, 2022 (2d) |
| Aug 17, 2022 | PCVX | ↓ Sell | 2,800 | $25.15 | $70K | Direct | Aug 19, 2022 (2d) |
| Jul 1, 2022 | PCVX | ↓ Sell | 2,800 | $22.00 | $62K | Direct | Jul 6, 2022 (5d) |
| Apr 18, 2022 | PCVX | ↓ Sell | 2,800 | $23.98 | $67K | Direct | Apr 20, 2022 (2d) |
| Feb 24, 2022 | PCVX | ↓ Sell | 10,000 | $22.00 | $220K | Direct | Feb 28, 2022 (4d) |
| Feb 22, 2021 | PCVX | ↓ Sell | 3,000 | $26.77 | $80K | Direct | Feb 24, 2021 (2d) |
| Jan 20, 2021 | PCVX | ↓ Sell | 3,000 | $25.50 | $77K | Direct | Jan 21, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PCVX insiders
Open-market trades in the last 12 months
About Jim Wassil's insider trades
Jim Wassil is EVP, Chief Scientific Ofc, COO at Vaxcyte (PCVX). Since Jan 20, 2021, Jim has reported no open-market purchases and 37 sales worth $12.7M on SEC Form 4. In the last 12 months: 9 sales ($3.0M).
Their filings also include option exercises (34 filings), shares withheld for taxes (12 filings), grants and awards (11 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PCVX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.